| Saxagliptin: a dipeptidyl peptidase-4 inhibitor ameliorates streptozotocin induced Alzheimer's disease J Kosaraju, CC Gali, RB Khatwal, A Dubala, S Chinni, RMD Holsinger, ... Neuropharmacology 72, 291-300, 2013 | 211 | 2013 |
| Amyloid-beta impairs insulin signaling by accelerating autophagy-lysosomal degradation of LRP-1 and IR-β in blood-brain barrier endothelial cells in vitro and in 3XTg-AD mice CC Gali, E Fanaee-Danesh, M Zandl-Lang, NM Albrecher, ... Molecular and Cellular Neuroscience 99, 103390, 2019 | 80 | 2019 |
| Regulatory effects of simvastatin and apoJ on APP processing and amyloid-β clearance in blood-brain barrier endothelial cells M Zandl-Lang, E Fanaee-Danesh, Y Sun, NM Albrecher, CC Gali, ... Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids …, 2018 | 70 | 2018 |
| Gestational diabetes mellitus modulates cholesterol homeostasis in human fetoplacental endothelium Y Sun, S Kopp, J Strutz, CC Gali, M Zandl-Lang, E Fanaee-Danesh, ... Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids …, 2018 | 48 | 2018 |
| Astaxanthin exerts protective effects similar to bexarotene in Alzheimer's disease by modulating amyloid-beta and cholesterol homeostasis in blood-brain barrier endothelial cells E Fanaee-Danesh, CC Gali, J Tadic, M Zandl-Lang, AC Kober, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1865 (9 …, 2019 | 44 | 2019 |
| Sex difference in flux of 27‐hydroxycholesterol into the brain C Parrado‐Fernandez, V Leoni, A Saeed, P Rodriguez‐Rodriguez, ... British Journal of Pharmacology 178 (16), 3194-3204, 2021 | 15 | 2021 |
| Differential effects of Alzheimer’s disease Aβ40 and 42 on endocytosis and intraneuronal trafficking RS Omtri, KJ Thompson, X Tang, CC Gali, U Panzenboeck, MW Davidson, ... Neuroscience 373, 159-168, 2018 | 12 | 2018 |
| Blood‐brain barrier insulin resistance decreases insulin uptake and increases amyloid beta uptake in Alzheimer's disease brain: Developing topics AL Zhou, SK Swaminathan, CC Gali, TJ Bruinsma, GL Curran, VV Sarma, ... Alzheimer's & Dementia 16, e047353, 2020 | 5 | 2020 |
| Intranasal lipid particulate drug delivery systems: An update on clinical challenges and biodistribution studies of cerebroactive drugs in Alzheimer’s disease D Arora, S Bhatt, M Kumar, HDC Vattikonda, Y Taneja, V Jain, V Joshi, ... Current Pharmaceutical Design 26 (27), 3281-3299, 2020 | 5 | 2020 |
| Novel Suberoylanilide Hydroxamic Acid Analogs Inhibit Angiogenesis and Induce Apoptosis in Breast Cancer Cells G Moku, S Vangala, V Yakati, CC Gali, S Saha, VS Madamsetty, A Vyas Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2022 | 3 | 2022 |
| Liver X receptor activation attenuates oxysterol-induced inflammatory responses in fetoplacental endothelial cells M George, M Lang, CC Gali, JA Babalola, C Tam-Amersdorfer, A Stracke, ... Cells 12 (8), 1186, 2023 | 2 | 2023 |
| A novel nutritional supplement reduces postprandial glucose response in healthy individuals in a randomised, placebo-controlled, crossover clinical study SP Guntupalli, M Karpuram, M Samala, CC Gali Nutrire 49 (2), 33, 2024 | 1 | 2024 |
| Glubloc™ Reduces Postprandial Blood Glucose Surge in Healthy Individuals (A Placebo Controlled Pilot study). CC Gali, L Palle | 1 | 2023 |
| A ready-to-mix nutraceutical supplement (GLUBLOC) lowers postprandial blood glucose levels in healthy individuals—A randomised, placebo-controlled, crossover study SG Konda, S Bhashyam, G Kasivelu, S Ramala, CC Gali Nutrire 49 (2), 1-13, 2024 | | 2024 |
| Safety Assessment of a Standardized Polyherbal Formulation (Glubloc™): Acute Toxicity Study and 28-Day Repeated Dose Toxicological Studies V Mayasa, P Raghuveer, PK Chintamaneni, CC Gali, UK Neerudu bioRxiv, 2023.09. 13.557515, 2023 | | 2023 |
| A placebo-controlled clinical study to assess the impact of variable complex weak magnetic fields (VCMF′ s) generated by the BeCurie™(Evolv28) device on the subjects with … MK Jonnalagadda, L Palle, SS Pasumarthi, CC Gali medRxiv, 2023.08. 03.23293534, 2023 | | 2023 |
| Nuclear receptors regulating inflammatory mediators in fetoplacental endothelial cells in gestational diabetes M George, CC Gali, C Tam-Amersdorfer, A Stracke, J Strutz, C Wadsack, ... DIABETOLOGIA 63 (SUPPL 1), S206-S206, 2020 | | 2020 |
| Gestational diabetes modulates cholesterol homeostasis in human fetoplacental endothelium Y Sun, S Kopp, CC Gali, M Zandl, E Fanaee-Danesh, I Bjorkhem, ... DIABETOLOGIA 60, S430-S430, 2017 | | 2017 |
| Gestational diabetes mellitus modulates cholesterol metabolism in human fetoplacental endothelial cells Y Sun, S Kopp, CC Gali, M Zandl, E Fanaee-Dane, I Björkhem, G Desoye, ... Atherosclerosis 263, e74-e75, 2017 | | 2017 |
| Interactions of simvastatin and APOJ with amyloid processing in cerebrovascular endothelial cells M Zandl, E Fanaee-Danesh, CC Gali, NM Albrecher, S Storck, A Saeed, ... Atherosclerosis 263, e85-e86, 2017 | | 2017 |
